TechValidate Customer Research Library
Saama Customer Statistic
67% of Global 500 pharma companies surveyed purchased Saama technology to reduce manual work.
Saama Customer Fact
For time savings of 25-50%.
Ashley Yocum, a Clinical Trial Manager/Director at Leukemia & Lymphoma Society, agrees that Saama is the number one AI clinical analytics platform company.
67% of Global 500 organizations surveyed use Saama to reduce time spent on manual work.
Since implementing Saama for its data needs, an S&P 500 healthcare company realized time savings up to 25%.
Saama Customer Satisfaction Rating
Brett Jennings, a Clinical Study Manager at Nephrology Associates of Chattanooga, is very likely to recommend Saama for providing:
Great integration of products into existing software to enhance capabilities.
Based on a response of 9 to the question “On a scale of 0-10, how likely would you be to recommend Saama?”
Saama Customer Testimonial
Using Saama’s machine learning approach, we’ve experienced faster discrepancy tracking and easier query management.
R&D Technologist, Global 500 Pharmaceuticals Company
To integrate source system data.
Since implementing Saama technology, A Global 500 pharmaceuticals company has realized a time savings of up to 50%.
“Saama is the number one AI clinical analytics platform company.”
That’s what the Leukemia & Lymphoma Society says about the Saama team.
One of the reasons a Clinical Data Manager at an S&P 500 healthcare company recommends Saama is:
Good customer follow-up on technical issues.
Based on a response of 7 to the question “On a scale of 0-10, how likely would you be to recommend Saama?”
An R&D Technologist at a Global 500 pharmaceuticals company agrees that:
We have enhanced our database search capabilities and streamlined the process to identify populations based on a specific set of criteria.
Brett Jennings, Clinical Study Manager, Nephrology Associates of Chattanooga
A Global 500 pharmaceuticals company strongly agrees that Saama’s technology is intuitive and easy to use.
The Nephrology Associates of Chattanooga strongly agrees that Saama technology is intuitive and easy to use.
Since implementing Saama for their data needs, Leukemia & Lymphoma Society has realized a cost savings of 10-25%.
A CRO Monitoring Oversight professional at a large enterprise professional services company would be very likely to recommend Saama for this reason:
I am working on a large, multi-protocol and multi-site program. The dashboard is helpful, distills down information across protocols, and then gives the ability to drill down.
71% of surveyed pharmaceutical professionals implemented Saama to reduce time spent on manual work.
An R&D Technologist at a Global 500 pharmaceuticals company would be very likely to recommend Saama for this reason:
Very Collaborative, Saama under-promises and over-delivers.
Based on a response of 10 to the question “On a scale of 0-10, how likely would you be to recommend Saama?”
The Leukemia & Lymphoma Society strongly agreed that Saama has been a valuable technology partner to their organization.
100% of surveyed biopharma organizations have realized a cost savings of up to 10% since implementing Saama for their data needs.
More Research on Saama